These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 199667)
1. Thymus-derived lymphocyte-dependent rejection of syngeneic papovavirus (SV40) and methylcholanthrene tumors in inbred hamsters. Blasecki JW J Immunol; 1977 Nov; 119(5):1621-6. PubMed ID: 199667 [TBL] [Abstract][Full Text] [Related]
2. Identification, functional characterization and partial purification of thymus-derived lymphocytes in inbred hamsters. Blasecki JW; Houston KJ Immunology; 1978 Jul; 35(1):1-11. PubMed ID: 308040 [TBL] [Abstract][Full Text] [Related]
3. Age-related and thymus-dependent rejection of adenovirus 2-transformed cell tumors in the Syrian hamster. Cook JL; Lewis AM; Kirkpatrick CH Cancer Res; 1979 Sep; 39(9):3335-40. PubMed ID: 314331 [TBL] [Abstract][Full Text] [Related]
4. Rejection of adenovirus 2-transformed cell tumors and immune responsiveness in Syrian hamsters. Cook JL; Kirkpatrick CH; Rabson AS; Lewis AM Cancer Res; 1979 Dec; 39(12):4949-55. PubMed ID: 315273 [TBL] [Abstract][Full Text] [Related]
5. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells. Blasecki JW; Tevethia SS J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278 [TBL] [Abstract][Full Text] [Related]
6. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Newmaster RS; Mylin LM; Fu TM; Tevethia SS Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors. Chapes SK; Gooding LR J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384 [TBL] [Abstract][Full Text] [Related]
8. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride. Coggin JH; Gillis LD; Payne WJ J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses. Roberts LK J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813 [TBL] [Abstract][Full Text] [Related]
10. Tumorigenicity of simian virus 40-transformed rat hepatocytes. Isom HC; Tevethia MJ; Kreider JW Cancer Res; 1981 Jun; 41(6):2126-34. PubMed ID: 6263461 [TBL] [Abstract][Full Text] [Related]
11. Cooperation between early acting delayed-type hypersensitivity T-cells and cultured effector cells in tumor rejection. Trial J Cancer Res; 1988 Nov; 48(21):5922-6. PubMed ID: 3262417 [TBL] [Abstract][Full Text] [Related]
12. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]
13. Surface antigens of BK virus-induced tumor cells. Karjalainen HE Med Biol; 1981 Feb; 59(1):35-40. PubMed ID: 6267387 [TBL] [Abstract][Full Text] [Related]
14. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas. Kumar V; Bennett M J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033 [TBL] [Abstract][Full Text] [Related]
15. Mitogenic and antimitogenic transforming growth factors secreted by adenovirus 2- and simian virus 40-transformed hamster cells: possible roles in promoting tumorigenesis. Akagi K; Murai K; Haddada H; Levine AS; Patch CT Cancer Res; 1987 Aug; 47(15):4086-92. PubMed ID: 3038307 [TBL] [Abstract][Full Text] [Related]
16. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft. Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758 [TBL] [Abstract][Full Text] [Related]
17. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide. Marusić M Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429 [TBL] [Abstract][Full Text] [Related]
19. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor. Nagarkatti M; Kaplan AM J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794 [TBL] [Abstract][Full Text] [Related]
20. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10). Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]